« Back
Home /
Omadacycline

Omadacycline

Item no.	HY-14865-25mg
Manufacturer	MedChem Express
CASRN	389139-89-3
Amount	25 mg
Quantity options	100 mg 10 mM/1 mL 10 mg 1 ea 1 mg 25 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.85
Citations	[1]Durães F, et, al. Omadacycline: A Newly Approved Antibacterial from the Class of Tetracyclines. Pharmaceuticals (Basel). 2019 Apr 21;12(2):63.\|[2]Macone AB, et, al. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline. Antimicrob Agents Chemother. 2014;58(2):1127-35.\|[3]Zhanel GG, et, al. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent. Drugs. 2020 Feb;80(3):285-313.\|[4]Markham A, et, al. Omadacycline: First Global Approval. Drugs. 2018 Dec;78(18):1931-1937. Animal Feed Science and Technology. 2014 Dec;198:323-332.\|Ann Lab Med. 2021 May 1;41(3):293-301.\|Antibiotics (Basel). 2022, 11(10), 1298.\|Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00470-19.\|Antimicrob Agents Chemother. 2020 Feb 21;64(3):e02097-19.\|Antimicrob Agents Chemother. 2023 Jan 23;e0145922.\|Antimicrob Agents Chemother. 2024 Oct 29:e0105124.\|Clin Exp Pharmacol Physiol. 2023 Apr 22.\|Comput Intell Neurosci. 2022 Apr 25;2022:7636983.\|Cureus. 2024 Dec 1;16(12):e74917.\|Diagn Micr Infec Dis. 2020 Nov;98(3):115129.\|J Antibiot (Tokyo). 2022 Jun 27.\|J Clin Microbiol. 2020 Jan 28;58(2):e01603-19.\|Microbiol Spectr. 2022 Dec 8;e0323822.\|Microbiol Spectr. 2023 May 4;e0071823.\|Nat Microbiol. 2023 Mar;8(3):410-423.\|Nat Struct Mol Biol. 2023 Aug 7.\|Open Forum Infect Dis. 2024 Oct 11;11(11):ofae611.\|PLoS Biol. 2022 Sep 28;20(9):e3001808.\|Research Square Preprint. 2020 Jun.\|Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0063824.\|J Antimicrob Chemother. 2021 Feb 11;76(3):653-658.\|J Antimicrob Chemother. 2021 May 6;dkab141.\|Virulence. 2022 Dec;13(1):77-88.
Smiles	O=C(C1=C(O)[C@@H](N(C)C)[C@@](C[C@@]2([H])C(C(C3=C(O)C(CNCC(C)(C)C)=CC(N(C)C)=C3C2)=O)=C4O)([H])[C@@]4(O)C1=O)N
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	PTK 0796,Amadacycline
Shipping Condition	Cool pack
Available
Manufacturer - Type	Reference compound
Manufacturer - Applications	COVID-19-immunoregulation
Manufacturer - Targets	Antibiotic; Bacterial
Shipping Temperature	Blue Ice
Storage Conditions	-20°C (Powder, sealed storage, away from moisture and light)
Molecular Weight	556.65
Product Description	Omadacycline (PTK 0796), a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections[1][2][3][4].
Manufacturer - Research Area	Infection
Solubility	DMSO: 100 mg/mL (ultrasonic)\|Methanol: 125 mg/mL (ultrasonic)
Manufacturer - Pathway	Anti-infection
Isoform	Tetracycline
Clinical information	Launched

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-14865-25mg-safety-datasheet.pdf